申请人:J. URIACH & CIA. S.A.
公开号:EP0617032A1
公开(公告)日:1994-09-28
The present invention relates to new cyanomethylpyridine derivatives of formula I
wherein Y represents N or CH; R₁ represents fluoro or chloro; R₂ represents hydrogen or C₁₋₄ alkyl; m is 0, 1 or 2; n is 0 or 1; p is 0 or 1; A represents a covalent bond or a group of formula -CONHCH(Ar)-, -NHCH(Ar)-, -SO₂NHCH(Ar)-, -NHCONHCH(Ar)- or -OC(=O)NHCH(Ar)-, and when p is 1, A can also represent -CH(Ar)NH-; and Ar represents phenyl or phenyl substituted with one or more groups chosen from halogen, C₁₋₄ alkyl, C₁₋₄ alkoxy or trifluoromethyl. These compounds are PAF antagonist and/or 5-lipoxygenase inhibitors.
本发明涉及式 I 的新氰基甲基吡啶衍生物
其中 Y 代表 N 或 CH;R₁ 代表氟或氯;R₂ 代表氢或 C₁₋₄ 烷基;m 为 0、1 或 2;n 为 0 或 1;p 为 0 或 1;A 代表共价键或-CONHCH(Ar)-、-NHCH(Ar)-、-SO₂NHCH(Ar)-、-NHCONHCH(Ar)- 或-OC(=O)NHCH(Ar)-式中的基团,当 p 为 1 时,A 也可以代表-CH(Ar)NH-;Ar 代表苯基或被一个或多个基团取代的苯基,这些基团选自卤素、C₁₋₄ 烷基、C₁₋₄ 烷氧基或三氟甲基。这些化合物是 PAF 拮抗剂和/或 5-脂氧合酶抑制剂。